Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 19617 NEW YORK, NY
Back to XFOR Full portfolio

Position in XFOR

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$156,687
+$156,551 QoQ
Shares Held
33,552
+101572.7% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 89 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in XFOR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,031 across 424 Biotechnology names. XFOR ranks #248 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in XFOR

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $156,687 33,552
2026-03-31 $136 33
2025-12-31 $18,324 4,581
2025-09-30 $112 33
2025-06-30 $62 33
2025-03-31 $39,042 165,438
2024-12-31 $337,384 459,653
2024-09-30 $51,162 76,476
2024-06-30 $43,063 74,247
2024-03-31 $71,066 51,127
2023-12-31 $66,956 79,805
2023-09-30 $86,987 79,805
2023-06-30 $185,198 95,463
2023-03-31 $544,660 626,047
2022-12-31 $118,760 119,598
2021-12-31 $464 203
2021-06-30 $307,670 47,334
2021-03-31 $396,275 46,025
2020-12-31 $251,579 39,126
2020-09-30 $58,438 8,632
2020-06-30 $155,643 16,700
2020-03-31 $38,168 3,817